Researchers in Nikolaus Rajewsky’s lab at Max Delbrück Center combined high-resolution, single-cell spatial technologies to map a tumor’s cellular neighborhoods in 3D and identify potential targets for personalized cancer therapy. They describe their…
The Helmholtz Institute for Translational AngioCardioScience (HI-TAC) invites attendees to its first Symposium on April 28 and 29, 2025. Researchers from around the world will meet at Heidelberg University to discuss how the heart and blood vessels…
Eckert & Ziegler Radiopharma GmbH (EZR), a 100% subsidiary of Eckert & Ziegler SE, today announced the signing of a manufacturing agreement with Pentixapharm, a clinical-stage biopharmaceutical company. Under the terms of the agreement, EZR will…
An African and European research consortium receives €1.5 million from the European Union and additional resources from the Swiss government to support the accumulation of knowledge, skills and innovative capacities for drug discovery in sub-Saharan…
The Helmholtz Association is pooling its commitment to prevention research with the launch of the Helmholtz Health Prevention Task Force. In a strategy paper published in “Nature Medicine,“ the committee outlines initial concepts for integrating…
REMATIQ, the first AI-native platform for automated product compliance in MedTech, has raised €5.4 million in a seed funding round. The round is led by Project A Ventures, with participation from Amino Collective and HelloWorld, and complemented by…
• 20,500 visitors, 900 exhibitors from almost 30 countries and 470 speakers in 200 sessions
• PAICON wins DMEA nova Award for the most convincing digital health idea
• DMEA 2026 from April 21 to 23, 2026
Max Delbrück Center and Helmholtz Imaging scientists have developed open-source software that simplifies the study of cell polarity with fluorescence microscopy. Published in “Nature Communications,” the innovation may streamline research on many…
Effect of mechanical stress on cartilage degradation studied in vitro
Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) and Actinium Pharmaceuticals, Inc. announced that they have entered into an agreement for the supply of Actinium-225 (Ac-225). With this agreement, Actinium Pharmaceuticals will have access to Eckert &…
